-
Product Insights
Likelihood of Approval Analysis for Pleural Disease
Overview How likely is it that the drugs in Pleural Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pleural Disease Overview Pleural disorders encompass a spectrum of conditions affecting the...
-
Product Insights
NewLeishmaniasis (Kala-Azar) – Drugs In Development, 2024
Empower your strategies with our Leishmaniasis (Kala-Azar) – Drugs In Development, 2024 report and make more profitable business decisions. Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include weight loss, low blood counts, enlargement of the liver and spleen, and fever. Treatment includes anti-parasitic drugs. The Leishmaniasis (Kala-Azar) drugs in development market research report provide comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar), complete...
-
Product Insights
NewTrypanosomiasis – Drugs In Development, 2024
Empower your strategies with our Trypanosomiasis – Drugs In Development, 2024 report and make more profitable business decisions. Trypanosomiasis, also known as sleeping sickness in humans and nagana in animals, is a parasitic disease caused by protozoan parasites of the genus Trypanosoma. There are two main forms of the disease, each caused by different species of Trypanosoma. African trypanosomiasis (sleeping sickness) is transmitted by tsetse flies and is predominantly found in sub-Saharan Africa. It is caused by two subspecies of the...
-
Product Insights
NewCryptococcal Meningitis – Drugs In Development, 2024
Empower your strategies with our Cryptococcal Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Cryptococcal meningitis is a fungal infection of the meninges, the tissues that cover the brain and spinal cord. The infection is caused by the fungus Cryptococcus, which spreads from the lungs to the brain. Symptoms include headache, fever, confusion, cough, achy chest, rash. Definitive diagnosis of cryptococcal meningitis is made by culture from the CSF. Antifungal agents for the treatment of cryptococcal...
-
Product Insights
NewFungal Meningitis – Drugs In Development, 2024
Empower your strategies with our Fungal Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Fungal meningitis a rare, non-contagious, life-threatening fungal infection that causes swelling of the areas around the brain and spinal cord. It is caused due to breathing in fungal spores. The infection can spread from the lungs to the brain or spinal cord. Candida albicans and Cryptococcus neoformans are the most common fungi responsible for meningitis. Symptoms include fever, headache, stiff neck, light...
-
Product Insights
NewAfrican Trypanosomiasis – Drugs In Development, 2024
Empower your strategies with our African Trypanosomiasis – Drugs In Development, 2024 report and make more profitable business decisions. African trypanosomiasis (also known as African sleeping sickness) is a parasitic infection caused by a species of parasite, Trypanosoma brucei, which is transmitted to humans through the bite of the tsetse fly. Symptoms include anxiety, drowsiness during the day, fever, headache, insomnia at night, mood changes, sleepiness (may be uncontrollable), sweating, swollen lymph nodes all over the body, weakness, and a swollen,...
-
Product Insights
NewOnchocerciasis (River Blindness) – Drugs In Development, 2024
Empower your strategies with our Onchocerciasis (River Blindness) – Drugs In Development, 2024 report and make more profitable business decisions. Onchocerciasis, or river blindness, is a neglected tropical disease (NTD) caused by the parasitic worm Onchocerca volvulus. It is transmitted through repeated bites by blackflies of the genus Simulium. The disease is called river blindness because the blackfly that transmits the infection lives and breeds near fast flowing streams and rivers. The infection can result in visual impairment and sometimes blindness....
-
Product Insights
NewMeningitis – Drugs In Development, 2024
Empower your strategies with our Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Meningitis is the inflammation of the meninges, protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening, depending on its cause. Viral meningitis is not life-threatening; those affected can be...
-
Product Insights
NewNematodal (Round Worm) Infections – Drugs In Development, 2024
Empower your strategies with our Nematodal (Round Worm) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Nematode infections are parasitic diseases caused by helminths (worms) living in the human intestine. The Nematodal (Round Worm) Infections drugs in development market research report provide comprehensive information on the therapeutics under development for Nematodal (Round Worm) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report...
-
Product Insights
NewChagas Disease (American Trypanosomiasis) – Drugs In Development, 2024
Empower your strategies with our Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2024 report and make more profitable business decisions. Chagas disease, or American trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting, and swollen glands. Treatment includes antiparasitic medications. The Chagas Disease (American Trypanosomiasis) drugs in development market research report provide comprehensive information on the therapeutics under development...